Conditions: Infertility
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 270
Healthy volunteers: no

Brief summary:
The purpose of the non-inferiority study is to evaluate the clinical efficacy and the safety of two different subcutaneous hMG preparations when administered to patients undergoing controlled ovarian stimulation for IVF.

Detailed description:

Arms:
arm 1: New hMG preparation. arm 2: None

Interventions: intervention 1: Menotropins intervention 2: Menotropins
Intervention descriptions: intervention 1: Daily administration, SC, starting dose 150 IU or 225 IU depending on patient age. intervention 2: Daily administration, SC, starting dose 150 IU or 225 IU depending on patient age.

Protocol document: